HIGHLIGHTS
- who: Sellem et_al BMC Ophthalmology and collaborators from the Centre Ophtalmologique Kléber, Cours Franklin Roosevelt, Lyon, France have published the research: Predictors of additional intraocular pressure reduction in patients changed to latanoprost/timolol fixed combination, in the Journal: (JOURNAL)
- what: The aim of this study was to identify predictors of an additional 10% intraocular pressure (IOP) reduction after 12 weeks of treatment with latanoprost/timolol fixed combination (FC) in patients requiring a change in their previous ocular hypotensive medication. In all, 391 subjects received at least one dose of the FC and were included . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.